Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics.

MLA

Voget, Rabea, et al. “Development of an Active-Site Titrant for SARS-CoV-2 Main Protease as an Indispensable Tool for Evaluating Enzyme Kinetics.” Acta Pharmaceutica Sinica. B, vol. 14, no. 5, May 2024, pp. 2349–57. EBSCOhost, https://doi.org/10.1016/j.apsb.2024.03.001.

APA

Voget, R., Breidenbach, J., Claff, T., Hingst, A., Sylvester, K., Steinebach, C., Vu, L. P., Weiße, R. H., Bartz, U., Sträter, N., Müller, C. E., & Gütschow, M. (2024). Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics. Acta Pharmaceutica Sinica. B, 14(5), 2349–2357. https://doi.org/10.1016/j.apsb.2024.03.001

Chicago

Voget, Rabea, Julian Breidenbach, Tobias Claff, Alexandra Hingst, Katharina Sylvester, Christian Steinebach, Lan Phuong Vu, et al. 2024. “Development of an Active-Site Titrant for SARS-CoV-2 Main Protease as an Indispensable Tool for Evaluating Enzyme Kinetics.” Acta Pharmaceutica Sinica. B 14 (5): 2349–57. doi:10.1016/j.apsb.2024.03.001.